Article Information
History
- March 24, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Constantine I. Vardavas1,2,*,
- Alexander G. Mathioudakis3,4,
- Katerina Nikitara1,
- Kimon Stamatelopoulos5,
- Georgios Georgiopoulos5,
- Revati Phalkey6,7,
- Jo Leonardi-Bee6,
- Esteve Fernandez8,
- Dolors Carnicer-Pont8,9,
- Jørgen Vestbo3,4,
- Jan C. Semenza10,
- Charlotte Deogan10,
- Jonathan E. Suk10,
- Piotr Kramarz10,
- Favelle Lamb10 and
- Pasi Penttinen10
- 1School of Medicine, University of Crete, Heraklion, Crete, Greece
- 2Department of Oral Health Policy and Epidemiology, Harvard School of Dental Medicine, Harvard University, Boston, MA, USA
- 3Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK
- 4North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
- 5Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
- 6Centre for Evidence Based Healthcare, Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, UK
- 7Heidelberg Institute of Global Health, University of Heidelberg, Germany
- 8Catalan Institute of Oncology, Barcelona, Spain
- 9Institut d’Investigació Biomèdica de Bellvithe (IDIBELL), Barcelona, Spain
- 10European Centre for Disease Prevention and Control (ECDC), Sweden
- ↵* Corresponding author; email: vardavasc{at}uoc.gr
Posted March 24, 2022.
Prognostic factors for mortality, ICU and hospital admission due to SARS-CoV-2: A systematic review and meta-analysis of cohort studies in Europe
